Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trialPhilip M. Bath, Nadia Frowd, Lesley Cala et al.|The Lancet|2019Cited by 196
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B. Coutts, Robert Simister, Sandeep Ankolekar et al.|The Lancet|2024Cited by 134